Interventional neuroradiology of the head and neck

American Journal of Neuroradiology

Volumn 29, Issue 10, 2008, Pages 1806-1815

  Gandhi, Dheeraj ^a,b   Gemmete, J J ^a   Ansari, S A ^a   Gujar, S K ^a   Mukherji, S K ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN BLOOD VESSEL; HEAD AND NECK DISEASE; HUMAN; INTERVENTIONAL RADIOLOGY; NEUROIMAGING; NEURORADIOLOGY; REVIEW; VASCULARIZATION;

HEAD; HUMANS; NECK; NEURORADIOGRAPHY; RADIOLOGY, INTERVENTIONAL; SURGERY, COMPUTER-ASSISTED;

EID: 56849107326     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1211     Document Type: Review

References (67)

1. Gupta S, Henningsen JA, Wallace MJ, et al. Percutaneous biopsy of head and neck lesions with CT guidance: various approaches and relevant anatomic and technical considerations. Radiographics 2007;272:371-90
2. Sherman PM, Yousem DM, Loevner LA. CT-guided aspirations in the head and neck: assessment of the first 216 cases. AJNR Am J Neuroradiol 2004;25:1603-07
3. Akins EW, Hawkins IF Jr, Mladinich C, et al. The blunt needle: a new percutaneous access device. AJR Am J Roentgenol 1989;152:181-82
4. Mukherji SK, Turetsky D, Tart RP, et al. A technique for core biopsies of head and neck masses. AJNR Am J Neuroradiol 1994;15:518-20
5. DelGaudio JM, Dillard DG, Albritton FD, et al. Computed tomography-guided needle biopsy of head and neck lesions. Arch Otolaryngol Head Neck Surg 2000;126:366-70
6. Brook A, Gold MM, Miller TS. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. J Vasc Interv Radiol 2008;19:725-35. Epub 2008 Mar 17
7. Rhim H, Dodd GD 3rd. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999;27:221-29
8. Shafir M, Shapiro R, Sung M, et al. Cryoablation of unresectable malignant liver tumors. Am J Surg 1996;171:27-31
9. Schirmang TC, Davis LM, Nigri PT, et al. Solitary fibrous tumor of the buccal space: treatment with percutaneous cryoablation. AJNR Am J Neuroradiol 2007;28:1728-30
10. Bui Q, Dupuy DE. Percutaneous CT-guided radiofrequency ablation of an adenoid cystic carcinoma of the head and neck. AJR Am J Roentgenol 2002;179:1333-35
11. Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 2006;244:296-304
12. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-20
13. Enjolras O, Mulliken JB. Clinical and laboratory investigations: the current management of vascular birthmarks. Pediatr Dermatol 1993;10:311-33
14. Yakes WF. Extremity venous malformations: diagnosis and management. Semin Intervention Radiol 1994;11:332-39
15. Claudon M, Upton J, Burrows PE. Diffuse venous malformations of the upper limb: morphologic characterization by MRI and venography. Pediatr Radiol 2001;31:507-14
16. Burrows PE, Laor T, Paltiel H, et al. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998;16:455-88
17. Berenguer B, Burrows PE, Zurakowski D, et al. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999;104:1-11, discussion 12-15
18. Choi YH, Han MH, O-Ki K, et al. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol 2002;13:475-82
19. Cordes BM, Seidel FG, Sulek M, et al. Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations. Otolaryngol Head Neck Surg 2007;137:962-64
20. Lee BB, Do YS, Byun HS, et al. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 2003;37:533-38
21. Cabrera J, Cabrera J Jr, Garcia-Olmedo A, et al. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003;139:1409-16
22. Rho MH, Kim DW, Kwon JS, et al. OK-432 sclerotherapy of plunging ranula in 21 patients: it can be a substitute for surgery. AJNR Am J Neuroradiol 2006;27:1090-95
23. Kim KH, Sung MN, Rho JL, et al. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg 2004;131:307-16
24. Chang HS, Yoon JH, Chung WY, et al. Sclerotherapy with OK-432 for recurrent cystic thyroid nodule. Yonsei Med J 1998;39:367-71
25. Macpherson P. The value of pre-operative embolization of meningiomas estimated subjectively and objectively. Neuroradiology 1991;33:334-37
26. Dean BL, Flom RA, Wallace RC, et al. Efficacy of endovascular treatment of meningiomas: evaluation with matched samples. AJNR Am J Neuroradiol 1994;15:1675-80
27. Wakhloo AK, Juengling FD, Delthoven VV. Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques. AJNR Am J Neuroradiol 1993;14:571-82
28. Kallmes DF, Evans AJ, Kaptain GJ, et al. Hemorrhagic complications in embolization of a meningioma: case report and review of the literature. Neuroradiology 1997;39:877-80
29. Quadros RS, Gallas S, Delcourt C, et al. Preoperative embolization of a cervicodorsal paraganglioma by direct percutaneous injection of Onyx and endovascular delivery of particles. AJNR Am J Neuroradiol 2006;27:1907-09
30. Abud DG, Mounayer C, Benndorf G, et al. Intratumoral injection of cyanoacrylate glue in head and neck paragangliomas. AJNR Am J Neuroradiol 2004;25:1457-62
31. Gruber A, Bavinzski G, Killer M, et al. Preoperative embolization of hypervascular skull base tumors. Minim Invasive Neurosurg 2000;43:62-71
32. Erdmann MW, Jackson JE, Davies DM, et al. Multidisciplinary approach to the management of head and neck arteriovenous malformations. Ann R Coll Surg Engl 1995;77:53-59
33. Arat A, Cil BE, Vargel I, et al. Embolization of high-flow craniofacial vascular malformations with Onyx. AJNR Am J Neuroradiol 2007;28:1409-14
34. Lee BB, Do YS, Yakes W, et al. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 2004;39:590-600
35. Rodesch G, Soupre V, Vazquez MP, et al. Arteriovenous malformations of the dental arcades: the place of endovascular therapy - results in 12 cases are presented. J Craniomaxillofac Surg 1998;26:306-13
36. Resnick SA, Russell EJ, Hanson DH, et al. Embolization of a life-threatening mandibular vascular malformation by direct percutaneous transmandibular puncture. Head Neck 1992;14:372-79
37. Ryu CW, Whang SM, Suh DC, et al. Percutaneous direct puncture glue embolization of high-flow craniofacial arteriovenous lesions: a new circular ring compression device with a beveled edge. AJNR Am J Neuroradiol 2007;28:528-30
38. Turowski B, Zanella FE. Interventional neuroradiology of the head and neck. Neuroimaging Clin N Am 2003;13:619-45
39. Andersen PJ, Kjeldsen AD, Nepper-Rasmussen J. Selective embolization in the treatment of intractable epistaxis. Acta Otolaryngol 2005;125:293-97
40. Layton KF, Kallmes DF, Gray LA, et al. Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 2007;28:885-88
41. Strutz J, Schumacher M. Uncontrollable epistaxis, angiographic localization and embolization. Arch Otolaryngol Head Neck Surg 1990;116:697-99
42. Tseng EY, Narducci CA, Willing SJ, et al. Angiographic embolization for epistaxis: a review of 114 cases. Laryngoscope 1998;108:615-19
43. Christensen NP, Smith DS, Barnwell SL, et al. Arterial embolization in the management of posterior epistaxis. Otolaryngol Head Neck Surg 2005;133:748-53
44. Remonda L, Schroth G, Caversaccio M, et al. Endovascular treatment of acute and subacute hemorrhage in the head and neck. Arch Otolaryngol Head Neck Surg 2000;126:1255-62
45. Morrissey DD, Anderson PE, Nesbit GM, et al. Endovascular management of hemorrhage in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1997;123:15-19
46. Goodman DN, Hoh BL, Rabinov JD, et al. CT angiography before embolization for hemorrhage in head and neck cancer. AJNR Am J Neuroradiol 2003;24:140-42
47. Sittel C, Jungelhulsing M, Gossmann A, et al. Superselective embolization as palliative treatment of recurrent hemorrhage in advanced carcinoma of the head and neck. Ann Otol Rhinol Laryngol 2001;110:1126-28
48. Wilner HI, Lazo A, Metes JJ, et al. Embolization in cataclysmal hemorrhage caused by squamous cell carcinoma of the head and neck. Radiology 1987;163:759-62
49. Chaloupka JC, Roth TC, Putman CM, et al. Recurrent carotid blowout syndrome: diagnosis and therapeutic challenges in a newly recognized subgroup of patients. AJNR Am J Neuroradiol 1999;30:1069-77
50. Mcdonald S, Gan J, Mckay AJ, et al. Endovascular treatment of acute carotid blowout syndrome. J Vasc Interv Radiol 2000;11:1184-88
51. Citardi MJ, Chaloupka JC, Son YH, et al. Management of carotid artery rupture by monitored endovascular therapeutic occlusion (1988-1994). Laryngoscope 1995;105:1086-92
52. Chaloupka JC, Putnam CM, Citardi MJ, et al. Endovascular therapy for the carotid blowout syndrome in head and neck surgical patients: diagnostic and managerial considerations. AJNR Am J Neuroradiol 1996;17:843-52
53. Lesley WS, Chaloupka JC, Weigele JB, et al. Preliminary experience with endovascular reconstruction for the management of carotid blowout syndrome. AJNR Am J Neuroradiol 2003;24:975-81
54. Chang FC, Lirng JF, Luo CB, et al. Carotid blowout syndrome in patients with head-and-neck cancers: reconstructive management by self-expandable stent-grafts. AJNR Am J Neuroradiol 2007;28:181-88
55. Chang FC, Lirng JF, Tai SK, et al. Brain abscess formation: a delayed complication of carotid blowout syndrome treated by self-expandable stent-graft. AJNR Am J Neuroradiol 2006;27:1543-45
56. Pyun HW, Lee DH, Yoo HM, et al. Placement of covered stents for carotid blowout in patients with head and neck cancer: follow-up results after rescue treatments. AJNR Am J Neuroradiol 2007;28:1594-98
57. Marcial VA, Pajak TF. Radiation therapy alone or in combination with surgery in head and neck cancer. Cancer 1985;55:2259-65
58. Laramore GE, Scott CB, Al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-13
59. Robertson AG, Soutar DS, Paul J, et al. Early closure of a randomized trial: surgery and postoperative radiotherapy versus radiotherapy in the management of intra-oral tumours. Clin Oncol (R Coll Radiol) 1998;10:155-60
60. Vokes EE, Weichselbaum RR. Concomitant chemotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8:911-34
61. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-90
62. Robbins KT, Kumar P, Wong FS, et al. Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients. Head Neck 2000;22:687-93
63. Kumar P, Robbins KT. Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: the "RADPLAT" protocol. Curr Oncol Rep 2001;3:59-65
64. Robbins KT, Kumar P, Regine WF, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997;38:263-71
65. Robbins KT, Wong FS, Kumar P, et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:670-75
66. Balm AJ, Rasch CR, Schornagel JH, et al. High dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 2004;26:485-93
67. Robbins KT, Kumar P, Harris J, et al. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. J Clin Oncol 2005;23:1447-54